| |||
MRDAC: An open-label, randomized, parallel group study comparing the efficacy and safety of Amlodipine in combination with Valsartan compared to Losartan in combination with Hydrochlorothiazide given for 52 weeks on the regression of left ventricular hypertrophy in patients with mild-to-moderate hypertension (EXAMINE Study)(in collaboration with Norvartis Pharma GmbH, Nürnberg)Projektbeschreibung:CVAA489ADE02, Novartis EXAMINE Studie.Projektlaufzeit: Projektbeginn: 01.07.2007Projektleitung: Hennig J, Bley T, Büchert M.Finanzierung:
Schlagworte:
Aktueller Forschungsbericht |